SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending as cannabis stocks surge amid reports that Trump may ease federal restrictions, sparking excitement among retail investors who anticipate a potential short squeeze. Community discussions revolve around the possibility of federal reclassification and its impact on the broader cannabis sector, with some emphasizing the potential for policy shifts to drive stock performance. Despite some skepticism, many anticipate significant gains if regulatory changes materialize.

Jiuzi Holdings, Inc. engages in franchise and operation of retail stores. The firm sells new energy vehicles (NEVs) under the brand name Jiuzi. It operates through the NEVs Sales and Franchise Services segments. The company was founded on October 10, 2019 and is headquartered in Hangzhou, China.

Jiuzi Holdings Inc

Jiuzi Holdings ($JZXN) is trending due to news of securing a commitment to expand its private placement to $1 billion, sparking excitement among traders. The community is drawing comparisons to other China-based runners like $SMX and $TGL, hoping for similar gains. However, concerns about potential dilution and Schwab blocking online trading are also being discussed.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is trending due to an initial positive reaction to earnings that quickly soured, with the stock dropping in after-hours trading. Despite a strong AI backlog and raised price targets from analysts, concerns over tighter AI margins and lack of clear 2026 guidance are fueling community discussion. Some investors believe this is a buying opportunity, while others fear a broader tech sector rotation.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst is trending following FDA approval of ORLADEYO oral pellets for young children with hereditary angioedema (HAE), making it the first and only targeted oral prophylactic therapy for HAE patients aged 2 and older. Community discussions revolve around the potential for a massive rally and significant short covering, although some traders express concern over share price movement despite positive news. The focus remains on BioCryst's long-term value and the impact of this approval on future sales.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies behind its mission to build a culture-focused cryptocurrency on the Solana blockchain, drawing parallels to Bitcoin. Discussions revolve around Weedcoin's potential within the evolving cannabis industry and its community-driven approach. Some users highlight hemp's phytoremediation properties, while others focus on culture and community.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending amid discussions about potential partnerships and its underlying technology, with community members weighing its strengths against other blockchains. Some traders are closely watching for breakout opportunities, while others express frustration with recent price action. The community is also actively discussing meme coins built on Solana, such as $WEEDCOIN and $PMV.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices surge to new highs, fueled by supply constraints and increasing industrial demand for use in green technologies like solar panels and EVs. Community discussions highlight bullish sentiment, particularly around a potential short squeeze and the metal's safe-haven appeal amid economic uncertainty. Some investors are expressing caution regarding overbought conditions and potential pullbacks.

Katapult Holdings, Inc. is an e-commerce focused financial technology company. The firm is engaged in the provision of e-commerce point-of-sale lease-purchase options for nonprime U.S. consumers. It offers its customers a lease purchase transaction processing system with no long-term obligation and options for ownership. The company was founded in August 2019 and is headquartered in Plano, TX.

Katapult Holdings Inc

KPLT is trending due to a merger announcement with The Aarons Company and CCF Holdings, sparking significant community discussion.  While some traders are celebrating quick profits and highlighting the potential for a squeeze, others are analyzing the implications of Katapult stockholders owning only 6% of the combined company. This deal creates an omnichannel financial solutions platform aimed at non-prime consumers.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending as investors react to news of the CEO's upcoming departure and anticipate the earnings report. The community is actively discussing potential upgrades, buyback programs, and the impact of international sales, while also considering whether a change in leadership can revitalize the brand's performance. Some traders are noting positive chart momentum, while others remain skeptical about long-term growth.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending amid discussions of its pipeline potential in treating cancers, particularly prostate cancer, and community excitement around positive trial data. Investors are speculating on potential buyouts and partnerships, while also noting the stock's undervaluation and high short interest, which could lead to a short squeeze. The company's upcoming R&D day is also generating buzz.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FOLDShares of Amicus Therapeutics (FOLD) rose by 14% on Thursday after the company made a deal with Teva Pharmaceuticals to settle their patent dispute. Teva wanted to sell a generic version of Amicus' drug GALAFOLD before its patent expired.&nbsp;According to the agreement, Teva can start selling the generic version in the U.S. in 2037, if it gets approved by the FDA. Both companies have agreed to drop all legal cases related to this issue.BofA raised its price target for Amicus shares to $15 from $13 while maintaining its ‘Buy’ rating on the stock. BofA sees this as a positive step since other similar legal cases with Aurobindo and Lupin are still unresolved. The settlement also eases worries that investors had about the ongoing legal risks.<figure class="image"><a href="https://stocktwits.com/symbol/FOLD"><img style="aspect-ratio:641/141;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_17_232351_f081877e12.png" alt="Screenshot 2024-10-17 232351.png" width="641" height="141"></a><figcaption>Amicus Therapeutics Inc’s sentiment meter as of 1:50 p.m. ET on Oct. 17, 2024 | Source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits has flipped to ‘extremely bullish’ (97/100) from ‘extremely bearish’ just a day ago.&nbsp;PIXYShares of ShiftPixy Inc (PIXY) jumped 78% on Thursday after the national staffing enterprise&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/pixy-stock-jumps-after-acquisition-of-turboscale/cJ2bf0eRIJ">announced</a> the acquisition of TurboScale, an AI technology company specializing in scalable GPU cloud infrastructure and AI model deployment.&nbsp;<figure class="image"><a href="https://stocktwits.com/symbol/PIXY"><img style="aspect-ratio:643/139;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_17_232837_c9a1f738e9.png" alt="Screenshot 2024-10-17 232837.png" width="643" height="139"></a><figcaption>ShiftPixy Inc’s sentiment meter as of 1:55 p.m. ET on Oct. 17, 2024 | Source: Stocktwits</figcaption></figure>PIXY became the top trending ticker on Stocktwits on Thursday morning after the announcement. Retail sentiment around the stock is more ‘extremely bullish’ (95/100) from ‘bearish’ a day ago.&nbsp;BXBlackstone shares soared 7% on Thursday after the firm posted third-quarter earnings that surpassed Wall Street expectations.Wells Fargo has maintained its ‘Overweight’ rating on the stock and set a price target of $169. The brokerage noted that while Blackstone's Q3 earnings per share (EPS) were better than expected, the improvements were of "fairly low quality," mainly due to favorable changes in the tax rate and other less reliable factors.&nbsp;<figure class="image"><a href="https://stocktwits.com/symbol/BX"><img style="aspect-ratio:643/141;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_17_233818_5961473307.png" alt="Screenshot 2024-10-17 233818.png" width="643" height="141"></a><figcaption>Blackstone Inc’s sentiment meter as of 1:50 p.m. ET on Oct. 17, 2024 | Source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits has shifted to ‘extremely bullish’ (94/100) from ‘bearish’ a day ago.&nbsp;For updates and corrections email newsroom@stocktwits.com.Read more:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tsmc-stock-surges-pre-market-on-quarterly-profit-jump/cJ2bJ8gRIE">TSMC Stock Surges Pre-Market, Lifting Apple and Nvidia After Quarterly Profit Jump – Retail Rejoices</a>

Amicus Therapeutics, ShiftPixy, and Blackstone experience significant stock surges as retail sentiment turns extremely bullish after key developments.

Amicus Therapeutics, ShiftPixt, Blackstone: Retail Investors Turn Most Bullish On These 3 Stocks

Amicus Therapeutics soared after resolving a patent dispute, while ShiftPixy jumped on its AI acquisition. Blackstone gained following a strong earnings report.

Equity

Shares of Florida-based national staffing enterprise ShiftPixy Inc (PIXY) jumped 150% on Thursday after the firm <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20241017922928/en/ShiftPixy-Inc.-Announces-Acquisition-of-TurboScale">announced</a> the acquisition of TurboScale, an AI technology company specializing in scalable GPU cloud infrastructure and AI model deployment.PIXY became the top trending ticker on Stocktwits on Thursday morning after the announcement. The deal size amounts to $150 million, which was structured with $75 million in stock and $75 million in debt.TurboScale CEO Chandler Song said ShiftPixy provides a perfect platform for many use cases of AI to blossom. “The two companies plan to build training and inference infrastructure for vertical AIs that include HR, Sales, Customer Services, and many more,” he said.ShiftPixy said that the acquisition will allow the firm to introduce enhanced AI-powered features, such as real-time predictive analytics and machine learning-driven automation, to streamline workforce management.“By integrating TurboScale’s advanced GPU cloud and AI technology, ShiftPixy will enhance its ability to optimize staffing efficiency, improve labor forecasting, and offer advanced AI-driven workforce solutions for clients across multiple industries,” the firm said.According to ShiftPixy, TurboScale’s platform offers cost-efficient, highly configurable virtual machines and private cloud solutions, tailored to meet the diverse needs of enterprises, from small experiments to large-scale AI deployments.Following the announcement, retail sentiment on Stocktwits jumped into the ‘extremely bullish’ territory (94/100), accompanied by 'extremely high' message volumes.<figure class="image"><a href="https://stocktwits.com/symbol/PIXY"><img style="aspect-ratio:1648/466;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_17_at_9_36_19_AM_915334dd1c.png" alt="PIXY sentiment meter as of 9:36 a.m. ET on Oct. 17, 2024 | Source: Stocktwits" width="1648" height="466"></a><figcaption>PIXY sentiment meter as of 9:36 a.m. ET on Oct. 17, 2024 | Source: Stocktwits</figcaption></figure>Shares of PIXY have recorded losses of over 83% on a year-to-date basis.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/blackstone-q3-tops-estimates/cJ2b90ARII">Blackstone Beats Q3 Estimates, AUM Reaches Record $1.11T: Stock Rises, But Retail Caution Lingers</a>For updates and corrections email newsroom@stocktwits.com

PIXY became the top trending ticker on Stocktwits on Thursday morning after the deal announcement | Representative Image Source: Pexels

PIXY Stock Jumps After Acquisition Of TurboScale: Retail Turns Extremely Bullish

The deal size amounts to $150 million, which was structured with $75 million in stock and $75 million in debt.

ShiftPixy, Inc. engages in the provision of human capital services. Its services include employment tax processing, human resources and employment compliance, employment related insurance, and employment administrative services solutions. The company was founded by Scott W. Absher and J. Stephen Holmes on June 3, 2015 and is headquartered in Miami, FL.

ShiftPixy Inc

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

PIXY
ShiftPixy Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest PIXY News

PIXYShiftPixy Inc